Results 261 to 270 of about 187,398 (301)

Impact of an Additional Therapy Guideline-Directed Medical Therapy on 30-Day Readmissions for Heart Failure with Reduced Ejection Fraction. [PDF]

Hosp Pharm
Peterson A, Davis S, Torres A, Ponce N, Benevides T, Kwon HI.   +5 more
europepmc   +1 more source

Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine

ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi, Alvin Chandra, Ambarish Pandey, Marco Metra   +3 more
wiley   +1 more source

Heart Failure With Reduced Ejection Fraction [PDF]

JAMA, 2020
Worldwide, the burden of heart failure has increased to an estimated 23 million people, and approximately 50% of cases are HF with reduced ejection fraction (HFrEF).Heart failure is a clinical syndrome characterized by dyspnea or exertional limitation due to impairment of ventricular filling or ejection of blood or both.
Sean P, Murphy, Nasrien E, Ibrahim, James L, Januzzi   +2 more
core   +7 more sources

Some of the next articles are maybe not open access.

Related searches:

Management of Heart Failure With Reduced Ejection Fraction

Current Problems in Cardiology, 2023
Heart failure with reduced ejection fraction (HFrEF) is a complex and progressive clinical condition characterized by dyspnea and functional impairment. HFrEF has a high burden of mortality and readmission rate making it one of the most significant public health challenges.
Ahmed Mustafa Rashid, Muhammad Shahzeb Khan, Marat Fudim, Tracy A. DeWald, Adam DeVore, Javed Butler   +5 more
openaire   +2 more sources

New pharmacotherapy for heart failure with reduced ejection fraction

Expert Review of Cardiovascular Therapy, 2020
The European Society of Cardiology (ESC), Canadian Cardiovascular Society, and the American College of Cardiology Heart Failure (HF) guidelines all currently recommend the use of Angiotensin Converting Enzyme (ACE) inhibitors or Angiotensin Receptor Blockers (ARBs) and Beta Blockers (BB) in the treatment of HF with a reduced ejection fraction (HFrEF ...
Sara Sotirakos, Peter Wheen, James Spiers, Richard Armstrong   +3 more
openaire   +2 more sources

Heart Failure: Heart Failure With Reduced Ejection Fraction.

FP essentials, 2021
Heart failure (HF) with reduced ejection fraction (HFrEF) is becoming more prevalent as the US population ages. Although the clinical presentation of HFrEF is remarkably similar to that of HF with preserved ejection fraction (HFpEF), the primary etiology may be different.
openaire   +1 more source

  blockers for heart failure with reduced ejection fraction

BMJ, 2011
#### Case scenario A 74 year old man attends the surgery for review of his longstanding heart failure. He has an exercise tolerance of just a few yards, limited by breathlessness. His jugular venous pressure is not raised, he has no ankle oedema, and the lung bases are clear. There is no evidence of fluid overload.
Derek G, Waller, James R, Waller
openaire   +2 more sources

Heart failure with mildly reduced ejection fraction

2023
Abstract The 2016 European Society of Cardiology (ESC) Heart Failure Guidelines introduced heart failure with mildly reduced ejection fraction (HFmrEF) as a separate category of patients. These patients have a left ventricular ejection fraction (LVEF) of between 40% and 50%.
Adriaan A Voors, Benda Moura, Lars Lund, Carolyn SP Lam   +3 more
openaire   +1 more source

Heart Failure with Reduced Ejection Fraction

2019
Heart failure with reduced ejection fraction (HF-REF) is a common problem worldwide and its prevalence rises with age. It is associated with substantial morbidity and mortality. Development of the condition is driven by a number of haemodynamic and neurohumoral pathophysiological processes which, in turn, lead to adverse remodelling of the myocardium ...
Alice M. Jackson, Pardeep S. Jhund
openaire   +1 more source